AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 42(4), 1990, pp. 386-393
Copyright © 1990 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathiot, C. C.
Right arrow Articles by Georges, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathiot, C. C.
Right arrow Articles by Georges, A. J.

An Outbreak of Human Semliki Forest Virus Infections in Central African Republic

Christian C. Mathiot, Gerard Grimaud, Philippe Garry, Jean Claude Bouquety, Augustin Mada, Anne Marie Daguisy AND Alain J. Georges
Pasteur Institute; Centre Medical de l'Ambassade de France; Elements Français d'Assistance Operationnelle; and Centre National Hospitalier Universitaire, Bangui, Central African Republic

Semliki Forest (SF) virus was responsible for an outbreak of febrile illnesses in Bangui, Central African Republic (CAR), during October–December 1987. The virus was isolated at first from mosquitoes, mainly Aedes africanus, collected August–October in a gallery forest 100 km from Bangui. During October–December, 22 isolations of SF virus were made from serum samples collected from patients in Bangui presenting with fever, severe persistent headache, myalgia, arthralgia, and a convalescence marked by asthenia. During the same period, 8 SF virus isolates were obtained from mosquitoes collected in Bangui, mainly from Ae. aegypti. Europeans, particularly soldiers who had recently arrived from France, were affected. Antibodies to alphaviruses had been previously detected in a high proportion of resident human populations in CAR. We conclude that SF virus is a human pathogen.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Ketola, A. Hinkkanen, F. Yongabi, P. Furu, A.-M. Maatta, T. Liimatainen, R. Pirinen, M. Bjorn, T. Hakkarainen, K. Makinen, et al.
Oncolytic Semliki Forest Virus Vector as a Novel Candidate against Unresectable Osteosarcoma
Cancer Res., October 15, 2008; 68(20): 8342 - 8350.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. Fragkoudis, L. Breakwell, C. McKimmie, A. Boyd, G. Barry, A. Kohl, A. Merits, and J. K. Fazakerley
The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons
J. Gen. Virol., December 1, 2007; 88(12): 3373 - 3384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society of Tropical Medicine and Hygiene.